Taiwan
WCC Biomedical 怡定興生醫 is a pioneering company founded in 2014, specializing in advanced biomedical Microneedle Path products. Their slogan "Total Solution Provider for Transdermal Microneedle System" reflects their commitment to providing a novel, effective, and painless transdermal drug delivery system (TDDS) for patients worldwide.
The company's founder, Dr. Ta-Jo Liu, brings a wealth of experience to WCC Biomedical, having served as a senior research scientist at Kodak (USA) Co. and as a professor and chairman at the Chemical Engineering Department of National Tsing Hua University. Dr. Liu's expertise in coating technology is evident from his establishment of Formosa Advanced Coating Co., Inc. in 1998. Notably, he has made significant contributions to the field, having served as the vice president of the International Society of Coating Science and Technology (ISCST) for two terms and receiving the prestigious John Tallmadge Award.
Despite limited details about specific industries served, WCC Biomedical's last recorded investment was a $1.33M Seed Round secured on 01 May 2020. Although the names of the investors are not specified, this injection of capital marks a significant milestone for the company based in Taiwan.
